series-a
Stage
1
Investors
About
Memento Medicines is a privately held Boston-based biotech company developing biologic therapies for retinal diseases, including a bispecific antibody that combines Tie2 agonism with VEGF inhibition.
Explore Memento Medicines's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.